Annual Revenue
$117.63 M
-$933.00 K-0.79%
December 31, 2023
Summary
- As of February 10, 2025, ACOR annual revenue is $117.63 million, with the most recent change of -$933.00 thousand (-0.79%) on December 31, 2023.
- During the last 3 years, ACOR annual revenue has fallen by -$35.33 million (-23.10%).
Performance
ACOR Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
$20.29 M
-$17.70 M-46.59%
March 31, 2024
Summary
- As of February 10, 2025, ACOR quarterly revenue is $20.29 million, with the most recent change of -$17.70 million (-46.59%) on March 31, 2024.
- Over the past year, ACOR quarterly revenue has dropped by -$1.97 million (-8.85%).
Performance
ACOR Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
TTM Revenue
$115.66 M
-$1.97 M-1.67%
March 31, 2024
Summary
- As of February 10, 2025, ACOR TTM revenue is $115.66 million, with the most recent change of -$1.97 million (-1.67%) on March 31, 2024.
- Over the past year, ACOR TTM revenue has dropped by -$2.63 million (-2.22%).
Performance
ACOR TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
ACOR Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -0.8% | -8.8% | -2.2% |
| 3 y3 years | -23.1% | -29.7% | -24.8% |
| 5 y5 years | -75.0% | -54.0% | -39.9% |
ACOR Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -8.9% | at low | -46.6% | at low | -10.4% | -3.9% |
| 5 y | 5-year | -38.9% | at low | -61.8% | at low | -39.9% | -3.9% |
| alltime | all time | -80.0% | -99.6% | -89.2% | -99.0% | -80.4% | -99.8% |
Acorda Therapeutics Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | - | $20.29 M(-46.6%) | $115.66 M(-1.7%) |
| Dec 2023 | $117.63 M(-0.8%) | $37.98 M(+37.1%) | $117.63 M(+5.9%) |
| Sep 2023 | - | $27.71 M(-6.6%) | $111.12 M(-5.0%) |
| Jun 2023 | - | $29.68 M(+33.3%) | $116.91 M(-1.2%) |
| Mar 2023 | - | $22.26 M(-29.3%) | $118.29 M(-0.2%) |
| Dec 2022 | $118.57 M(-8.1%) | $31.47 M(-6.1%) | $118.57 M(-4.4%) |
| Sep 2022 | - | $33.51 M(+7.9%) | $124.06 M(+1.7%) |
| Jun 2022 | - | $31.05 M(+37.8%) | $122.01 M(-0.6%) |
| Mar 2022 | - | $22.53 M(-39.0%) | $122.74 M(-4.9%) |
| Dec 2021 | $129.07 M(-15.6%) | $36.97 M(+17.5%) | $129.07 M(-0.9%) |
| Sep 2021 | - | $31.46 M(-1.0%) | $130.26 M(-14.2%) |
| Jun 2021 | - | $31.79 M(+10.1%) | $151.90 M(-1.2%) |
| Mar 2021 | - | $28.86 M(-24.4%) | $153.73 M(+0.5%) |
| Dec 2020 | $152.97 M(-20.5%) | $38.16 M(-28.1%) | $152.97 M(-7.5%) |
| Sep 2020 | - | $53.09 M(+57.9%) | $165.30 M(+3.4%) |
| Jun 2020 | - | $33.62 M(+19.6%) | $159.94 M(-9.3%) |
| Mar 2020 | - | $28.10 M(-44.4%) | $176.37 M(-8.3%) |
| Dec 2019 | $192.41 M(-59.2%) | $50.50 M(+5.8%) | $192.41 M(-8.8%) |
| Sep 2019 | - | $47.72 M(-4.7%) | $211.06 M(-31.1%) |
| Jun 2019 | - | $50.05 M(+13.4%) | $306.16 M(-25.2%) |
| Mar 2019 | - | $44.14 M(-36.2%) | $409.40 M(-13.2%) |
| Dec 2018 | $471.43 M(-19.9%) | $69.15 M(-51.6%) | $471.43 M(-20.2%) |
| Sep 2018 | - | $142.81 M(-6.8%) | $590.68 M(+0.3%) |
| Jun 2018 | - | $153.30 M(+44.4%) | $588.93 M(+2.4%) |
| Mar 2018 | - | $106.17 M(-43.6%) | $575.07 M(-2.2%) |
| Dec 2017 | $588.29 M(+13.2%) | $188.40 M(+33.6%) | $588.29 M(+8.8%) |
| Sep 2017 | - | $141.06 M(+1.2%) | $540.52 M(+1.0%) |
| Jun 2017 | - | $139.44 M(+16.8%) | $535.06 M(+2.3%) |
| Mar 2017 | - | $119.39 M(-15.1%) | $523.08 M(+0.7%) |
| Dec 2016 | $519.60 M(+5.5%) | $140.63 M(+3.7%) | $519.60 M(+1.9%) |
| Sep 2016 | - | $135.61 M(+6.4%) | $509.88 M(-2.4%) |
| Jun 2016 | - | $127.46 M(+10.0%) | $522.46 M(+2.7%) |
| Mar 2016 | - | $115.90 M(-11.5%) | $508.71 M(+3.3%) |
| Dec 2015 | $492.66 M(+22.7%) | $130.90 M(-11.7%) | $492.66 M(+2.7%) |
| Sep 2015 | - | $148.20 M(+30.3%) | $479.63 M(+9.7%) |
| Jun 2015 | - | $113.71 M(+13.9%) | $437.39 M(+3.9%) |
| Mar 2015 | - | $99.85 M(-15.3%) | $420.81 M(+4.8%) |
| Dec 2014 | $401.48 M | $117.87 M(+11.2%) | $401.48 M(+6.7%) |
| Sep 2014 | - | $105.96 M(+9.1%) | $376.20 M(+5.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2014 | - | $97.13 M(+20.6%) | $355.16 M(+2.9%) |
| Mar 2014 | - | $80.52 M(-13.0%) | $345.08 M(+2.6%) |
| Dec 2013 | $336.43 M(+10.0%) | $92.59 M(+9.0%) | $336.43 M(+3.4%) |
| Sep 2013 | - | $84.92 M(-2.5%) | $325.31 M(+2.4%) |
| Jun 2013 | - | $87.05 M(+21.1%) | $317.83 M(+3.7%) |
| Mar 2013 | - | $71.86 M(-11.8%) | $306.43 M(+0.2%) |
| Dec 2012 | $305.81 M(+4.6%) | $81.47 M(+5.2%) | $305.81 M(+3.0%) |
| Sep 2012 | - | $77.44 M(+2.4%) | $296.99 M(-5.0%) |
| Jun 2012 | - | $75.66 M(+6.2%) | $312.58 M(+3.4%) |
| Mar 2012 | - | $71.25 M(-1.9%) | $302.20 M(+3.4%) |
| Dec 2011 | $292.24 M(+53.0%) | $72.64 M(-21.9%) | $292.24 M(+2.0%) |
| Sep 2011 | - | $93.03 M(+42.5%) | $286.39 M(+11.4%) |
| Jun 2011 | - | $65.28 M(+6.5%) | $256.98 M(+9.6%) |
| Mar 2011 | - | $61.29 M(-8.3%) | $234.54 M(+22.8%) |
| Dec 2010 | $191.00 M(+249.4%) | $66.80 M(+5.0%) | $191.00 M(+37.8%) |
| Sep 2010 | - | $63.62 M(+48.5%) | $138.64 M(+53.6%) |
| Jun 2010 | - | $42.84 M(+141.4%) | $90.24 M(+50.5%) |
| Mar 2010 | - | $17.75 M(+22.9%) | $59.95 M(+9.7%) |
| Dec 2009 | $54.67 M(+14.3%) | $14.44 M(-5.1%) | $54.67 M(+3.8%) |
| Sep 2009 | - | $15.21 M(+21.2%) | $52.69 M(+5.5%) |
| Jun 2009 | - | $12.55 M(+0.6%) | $49.95 M(+2.4%) |
| Mar 2009 | - | $12.47 M(+0.1%) | $48.78 M(+2.0%) |
| Dec 2008 | $47.83 M(+21.1%) | $12.46 M(-0.0%) | $47.83 M(+2.7%) |
| Sep 2008 | - | $12.47 M(+9.5%) | $46.58 M(+4.5%) |
| Jun 2008 | - | $11.39 M(-1.1%) | $44.57 M(+4.4%) |
| Mar 2008 | - | $11.51 M(+2.7%) | $42.68 M(+8.1%) |
| Dec 2007 | $39.49 M(+44.4%) | $11.22 M(+7.2%) | $39.49 M(+9.7%) |
| Sep 2007 | - | $10.46 M(+10.2%) | $35.99 M(+13.3%) |
| Jun 2007 | - | $9.49 M(+14.2%) | $31.76 M(-0.3%) |
| Mar 2007 | - | $8.32 M(+7.7%) | $31.87 M(+16.5%) |
| Dec 2006 | $27.35 M(+431.5%) | $7.72 M(+24.0%) | $27.35 M(+22.4%) |
| Sep 2006 | - | $6.23 M(-35.2%) | $22.34 M(+19.1%) |
| Jun 2006 | - | $9.60 M(+152.7%) | $18.76 M(+104.9%) |
| Mar 2006 | - | $3.80 M(+40.0%) | $9.16 M(+70.9%) |
| Dec 2005 | $5.15 M(+973.1%) | $2.71 M(+2.7%) | $5.36 M(+102.7%) |
| Sep 2005 | - | $2.64 M(+1210.5%) | $2.64 M(+1210.5%) |
| Dec 2004 | $479.50 K(-44.0%) | - | - |
| Dec 2003 | $856.00 K(+80.7%) | - | - |
| Sep 2003 | - | $201.70 K | $201.70 K |
| Jun 2003 | $473.60 K | - | - |
FAQ
- What is Acorda Therapeutics annual revenue?
- What is the all time high annual revenue for Acorda Therapeutics?
- What is Acorda Therapeutics annual revenue year-on-year change?
- What is Acorda Therapeutics quarterly revenue?
- What is the all time high quarterly revenue for Acorda Therapeutics?
- What is Acorda Therapeutics quarterly revenue year-on-year change?
- What is Acorda Therapeutics TTM revenue?
- What is the all time high TTM revenue for Acorda Therapeutics?
- What is Acorda Therapeutics TTM revenue year-on-year change?
What is Acorda Therapeutics annual revenue?
The current annual revenue of ACOR is $117.63 M
What is the all time high annual revenue for Acorda Therapeutics?
Acorda Therapeutics all-time high annual revenue is $588.29 M
What is Acorda Therapeutics annual revenue year-on-year change?
Over the past year, ACOR annual revenue has changed by -$933.00 K (-0.79%)
What is Acorda Therapeutics quarterly revenue?
The current quarterly revenue of ACOR is $20.29 M
What is the all time high quarterly revenue for Acorda Therapeutics?
Acorda Therapeutics all-time high quarterly revenue is $188.40 M
What is Acorda Therapeutics quarterly revenue year-on-year change?
Over the past year, ACOR quarterly revenue has changed by -$1.97 M (-8.85%)
What is Acorda Therapeutics TTM revenue?
The current TTM revenue of ACOR is $115.66 M
What is the all time high TTM revenue for Acorda Therapeutics?
Acorda Therapeutics all-time high TTM revenue is $590.68 M
What is Acorda Therapeutics TTM revenue year-on-year change?
Over the past year, ACOR TTM revenue has changed by -$2.63 M (-2.22%)